|
Market Closed -
London S.E.
11:20:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
MarketScreener Strategies
Search
 | Roche Holding: Good Q2; late-stage pipeline execution key to sustained re-rating | July 23, 2026 at 11:34 am |
 | Roche posts unsurprising first-half results | July 23, 2026 at 03:30 am |
 | Roche Holding: An assuring start to the year | April 23, 2026 at 09:32 am |
 | The Price of Patience | April 23, 2026 at 05:17 am |
No results match your criteria
Filters
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
- News Roche Holding AG
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
